AVERNA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 29.526
EU - Europa 14.651
AS - Asia 12.295
SA - Sud America 2.178
AF - Africa 357
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 14
Totale 59.051
Nazione #
US - Stati Uniti d'America 29.080
SG - Singapore 4.416
RU - Federazione Russa 3.500
IT - Italia 3.291
CN - Cina 3.175
BR - Brasile 1.739
FI - Finlandia 1.659
VN - Vietnam 1.213
UA - Ucraina 1.211
HK - Hong Kong 1.197
DE - Germania 1.156
PL - Polonia 816
IE - Irlanda 686
GB - Regno Unito 681
FR - Francia 677
JP - Giappone 466
BD - Bangladesh 387
KR - Corea 279
IN - India 269
SE - Svezia 241
CA - Canada 211
TR - Turchia 180
NL - Olanda 155
AR - Argentina 150
MX - Messico 141
AT - Austria 113
IQ - Iraq 112
BE - Belgio 97
CI - Costa d'Avorio 79
ZA - Sudafrica 76
RO - Romania 73
PK - Pakistan 66
VE - Venezuela 64
EC - Ecuador 59
ES - Italia 59
UZ - Uzbekistan 57
CH - Svizzera 55
ID - Indonesia 52
MA - Marocco 47
MY - Malesia 47
CL - Cile 46
CO - Colombia 41
IR - Iran 40
SA - Arabia Saudita 40
JO - Giordania 35
AE - Emirati Arabi Uniti 33
GR - Grecia 33
KE - Kenya 33
NP - Nepal 30
PH - Filippine 30
AZ - Azerbaigian 29
PY - Paraguay 27
EG - Egitto 25
PE - Perù 24
AU - Australia 22
JM - Giamaica 22
DZ - Algeria 20
LT - Lituania 19
IL - Israele 18
CZ - Repubblica Ceca 17
PT - Portogallo 16
UY - Uruguay 15
BG - Bulgaria 14
CR - Costa Rica 14
KZ - Kazakistan 14
SN - Senegal 14
TN - Tunisia 14
TW - Taiwan 14
BO - Bolivia 13
TH - Thailandia 13
GE - Georgia 12
DO - Repubblica Dominicana 11
AL - Albania 10
HN - Honduras 10
NG - Nigeria 10
OM - Oman 10
PA - Panama 10
BH - Bahrain 9
RS - Serbia 9
HU - Ungheria 8
PS - Palestinian Territory 8
AO - Angola 7
DK - Danimarca 7
HR - Croazia 7
LB - Libano 7
LK - Sri Lanka 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
EU - Europa 6
MM - Myanmar 6
NI - Nicaragua 6
SI - Slovenia 6
BY - Bielorussia 5
ET - Etiopia 5
KG - Kirghizistan 5
MK - Macedonia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 58.977
Città #
Fairfield 3.655
Ashburn 3.545
Singapore 2.947
Woodbridge 1.901
Houston 1.634
Wilmington 1.559
Seattle 1.550
Chandler 1.523
San Jose 1.457
Cambridge 1.171
Hong Kong 1.150
Ann Arbor 849
Zgierz 721
Dublin 681
Jacksonville 645
Moscow 583
Medford 545
Beijing 529
Palermo 475
Council Bluffs 461
Tokyo 443
Santa Clara 402
Ho Chi Minh City 394
Nanjing 375
Dallas 361
Altamura 358
New York 354
Princeton 345
Los Angeles 341
Frankfurt am Main 339
Lauterbourg 324
Helsinki 305
Hanoi 276
Des Moines 265
Boardman 262
San Diego 258
Lawrence 249
Dearborn 209
Milan 189
Tulsa 178
Chicago 176
Hefei 165
Buffalo 153
São Paulo 145
Shenyang 136
London 124
Rome 113
The Dalles 109
Nanchang 108
Jinan 96
Hebei 91
Tianjin 90
Changsha 88
Ludwigshafen am Rhein 87
Orem 87
Seongnam 86
Brussels 85
Abidjan 79
Phoenix 78
Izmir 75
Munich 74
Jiaxing 67
Guangzhou 62
Haiphong 60
Da Nang 59
Rio de Janeiro 58
Mumbai 57
Nuremberg 57
Saint Petersburg 57
Amsterdam 55
Toronto 52
Atlanta 51
Chennai 51
Düsseldorf 48
Johannesburg 48
Ningbo 48
Venice 46
Warsaw 46
Zhengzhou 45
Tashkent 44
Belo Horizonte 43
Columbus 43
Shanghai 43
Salt Lake City 42
Verona 42
Montreal 40
Baghdad 39
Brooklyn 39
Vienna 39
Paris 38
San Mateo 38
San Paolo di Civitate 38
Hangzhou 37
Stockholm 37
Bremen 36
Naples 36
Denver 35
Lappeenranta 34
Falls Church 33
San Francisco 33
Totale 37.829
Nome #
Multiple food hypersensitivity as a cause of refractory chronic constipation in adults 490
Le Dislipidemie Genetiche. Il Progetto LIPIGEN 427
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. 401
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 387
A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach-Wiethe disease) from Sicily 304
Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy 295
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial 294
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 293
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 291
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 288
LINEE GUIDA CLINICHE PER LA PREVENZIONE DELLA CARDIOPATIA ISCHEMICA NELLA IPERCOLESTEROLEMIA FAMILIARE Una patologia sotto-diagnosticata e sotto-trattata 287
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 277
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 270
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 269
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 266
IL GENE PCSK9: UN NUOVO GENE IMPLICATO NEL CONTROLLO DELLA COLESTEROLEMIA 265
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 264
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 261
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 260
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 259
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. 259
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 258
Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. 258
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 258
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 255
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 253
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 252
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 251
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 250
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 249
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society 248
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 247
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 245
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. 245
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 243
Chronic constipation and food intolerance: a model of proctitis causing constipation 242
A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome 241
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 239
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 239
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 238
GASTROINTESTINAL SYMPTOMS IN INFANCY: A POPULATION-BASED PROSPECTIVE STUDY 238
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 238
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics 238
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 234
A novel component of the metabolic syndrome : The oxidative stress 233
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 233
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 232
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 230
A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain 228
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 226
Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. 225
Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient 225
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. 225
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 225
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 220
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 219
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 218
A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia. 217
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency 217
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 217
SEVERE MALABSORPTION AND DECREASED TRIGLYCERIDE RICH LIPOPROTEINS PRODUCTION IN A PROBAND CARRYING A MUTATION ENCODING FOR A TRUNCATED APOLIPOPROTEIN B100 VARIANT (APO B 34.8). 215
Familial hypercholesterolæmia in children and adolescents: Gaining decades of life by optimizing detection and treatment 214
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 214
LE IPERCOLESTEROLEMIE PRIMITIVE 213
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 213
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 213
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins 212
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. 211
The ANP Genetic Variant RS5068 is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population 210
HYPOBETALIPOPROTEINEMIA AND FATTY LIVER: WHO IS THE CULPRIT 209
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 209
Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia 208
Metabolomic analysis of plasma from Alzheimer disease patients 207
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 205
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 205
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 204
FAMILIAL LIGAND-DEFECTIVE APOLIPOPROTEIN B: IDENTIFICATION OF A FAMILY HARBOURING THE ARG3531CYS (FDB3531) OF THE APOB GENE 204
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 204
Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia 204
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” 204
MISSENSE MUTATION ALA34VAL IN EXON 2 OF THE LIPOPROTEIN LIPASE GENE IN A YOUNG MAN WITH CHYLOMICRONEMIA. 203
Gene expression in mouse spermatogenesis during ontogenesis. 203
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy 203
A Targeted ApoB38.9 Mutation in Mice Is Associated with Reduced Hepatic Cholesterol Synthesis and Enhanced Lipid Peroxidation. 202
Obesity and the metabolic syndrome in a student cohort from Southern Italy 202
Molecular diagnosis of hypobetalipoproteinemia: An ENID review 201
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 201
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 200
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 199
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 199
Cardiovascular efficacy and safety of bococizumab in high-risk patients 199
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 198
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 198
Role of Nutraceuticals in Hypolipidemic Therapy 197
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 197
PREVALENCE OF ANGPTL3 AND APOB GENE MUTATIONS IN SUBJECTS WITH COMBINED HYPOLIPIDEMIA 196
Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension 196
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 195
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 195
UNA NUOVA MUTAZIONE DELL’INTRONE 16 (G>A a 2390 -1) DEL RECETTORE DELLE LDL RESPONSABILE DI IPERCOLESTEROLEMIA FAMILIARE. EFFETTI SULLA ESPRESSIONE DELL’mRNA DEL RECETTORE DELLE LDL 194
Totale 23.812
Categoria #
all - tutte 207.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 0 0 0 0 0 0 461
2021/20223.897 147 837 146 125 102 152 169 229 543 481 231 735
2022/20234.678 503 934 113 485 550 713 203 323 499 58 190 107
2023/20242.310 106 339 164 253 164 513 241 118 28 72 60 252
2024/20256.171 151 323 405 468 230 228 427 495 525 632 844 1.443
2025/202621.320 1.330 771 1.176 1.508 1.823 3.052 3.026 2.293 1.782 2.983 940 636
Totale 60.792